A girl with severe fistulizing Crohn’s disease

Digestive and Liver Disease

Volumn 32, Issue 9, 2000, Pages 792-794

  Barabino, A ^a   Castellano, E ^a   Gandullia, P ^a   Biscaldi, E ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Cyclosporine related neurotoxicity; Fistulizing Crohn's disease; Infliximab

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; AZATHIOPRINE; C REACTIVE PROTEIN; CHOLESTEROL; CIPROFLOXACIN; CREATININE; CYCLOSPORIN; HEMOGLOBIN; INFLIXIMAB; ION; MESALAZINE; METHYLPREDNISOLONE; METRONIDAZOLE; NITROGEN; PHENOBARBITAL; PREDNISONE; STEROID; TOPICAL AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UREA;

ANUS FISTULA; ARTICLE; BASAL GANGLION; BRAIN CORTEX LESION; CASE REPORT; CEREBRAL BLINDNESS; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONVALESCENCE; CROHN DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOLLOW UP; GRAND MAL SEIZURE; HEADACHE; HUMAN; NEUROLOGIC EXAMINATION; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; TOTAL PARENTERAL NUTRITION; ULTRASOUND;

BRAIN DISEASES; CHILD; CROHN DISEASE; CYCLOSPORINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; RECTAL FISTULA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034486362     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(00)80357-6     Document Type: Article

References (22)

1. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A
2. Efficacy of cyclosporine in treatment of fistula of Crohn's disease
3. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine
4. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease
5. Cyclosporine treatment of inflammatory bowel disease
6. Cyclosporine as an alternative to surgery in children with inflammatory bowel disease
7. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease
8. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children
9. MR imaging of reversible cyclosporin A-induced neurotoxicity
10. Posterior leukoencephalopathy syndrome may not be reversible
11. Severe central nervous system toxicity after chronic treatment with cyclosporine
12. Cyclosporine-induced white and grey matter central nervous system lesions in a pediatric renal transplant patient
13. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
14. Infliximab for the treatment of fistulas in patients with Crohn's disease
15. Anti-TNF antibody in Crohn's disease - Status of information, comments and recommendations of an international working group
16. Tumour-necrosis-factor antibody treatment in Crohn's disease
17. TM, in pediatric patients with refractory Crohn's disease
18. A multicenter study of Infliximab (anti-TNFα antibody) in the treatment of children with active Crohn's disease
19. Collaborative experience of open-label Infliximab in refractory pediatric Crohn's disease
20. Preliminary report on the use of oral Tacrolimus (FK 506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease
21. Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunodulation by Tacrolimus (FK 506)
22. The use of tacrolimus in pediatric liver transplantation